Kewaunee Scientific Corporation

KEQU | NASDAQ | 0 Sledující

$57.60

3.50%

$1.95

Sledovat

Overview Metrics Financials

Breakdown	4/30/2024 USD	4/30/2023 USD	4/30/2022 USD	4/30/2021 USD
Total revenue	203,755 -7.17%	219,494 +29.98%	168,872 +14.51%	147,469 -
Cost of revenue	151,704 -17.51%	183,906 +27.14%	144,652 +17.15%	123,476 -
Gross profit	52,051 +46.26%	35,588 +46.94%	24,220 +0.95%	23,993 -
Operating expense	33,770 +11.73%	30,224 +12.66%	26,828 +6.00%	25,309 -
Operating income	18,281 +403.33%	3,632 +239.26%	-2,608 -98.18%	-1,316 -
Pretax Income	13,119 +191.66%	4,498 +281.01%	-2,485 +5.04%	-2,617 -
Tax Provision	-5,938 -289.17%	3,139 -10.77%	3,518 +255.35%	990 -
Net income	18,753 +1,279.91%	1,359 +122.64%	-6,003 -66.43%	-3,607 -
EPS	6.51 +1,256.25%	0.48 +122.33%	-2.15 -64.12%	-1.31 -
Diluted EPS	6.38 +1,257.45%	0.47 +121.86%	-2.15 -64.12%	-1.31 -
Average Shares	2,879 +1.95%	2,824 +1.36%	2,786 +0.94%	2,760 -
Diluted Average Shares	2,938 +1.24%	2,902 +4.16%	2,786 +0.94%	2,760 -
EBIT	14,918 +181.84%	5,293 +385.64%	-1,853 +16.83%	-2,228 -
EBITDA	18,043 +121.12%	8,160 +790.83%	916 +99.56%	459 -

Soubory cookie používáme ke zlepšení prohlížení na webu.